Authors
Astha Vyas, Ganga Sharma
Abstract
Osteoporosis is a very common or silent disease and disorder without any evidence of diseases till a fracture happens. In the world, around 200 million individuals are affected because of osteoporosis and 8.9 million fractures happen in individuals. Hip fractures are foremost health problem by means of both health disorder and social cost of the ageing people for the reason that these related fractures are one of the chief reasons of morbidity, damage, decrease quality of life and death in women as well as men. The main objective of the paper is to examine the risk issues connected to the huge effect of fractures related with osteoporotic and inhibiting of disease. Osteoporosis’s increasing trend is attended by an underutilization of present defensive approaches and at high fracture risk, only small number of patients are known and consecutively mentioned to as therapy. In indication and management of osteoporosis, it delivers diagnostic evidence to evaluate the best practices for adoption of an accurate healthcare approach to considerably decrease osteoporosis load. Main focus on attention towards identification of high fracture risk among osteoporosis patients. Keywords: Osteoporosis, Fracture Prevention, Morbidity Keywords: Osteoporosis, Fracture Prevention, Morbidity
Introduction
Osteoporosis is a silent skeletal and disease disorder characterized by small density of bone and micro-architectural weakening of skeletal tissue. It increases in fracture jeopardy factor which is major health problem and breaks that happen consisting nominal trauma and in certain cases, without any trauma. With the case of osteoporosis hip, vertebral, and wrist fractures are best commonly associated? This fracture contains annual cost in Wales and England is £1.7 billion in which 90% of the price was occurred by fracture of hip. In the United States, the total cost of osteoporosis is estimated to be over $14 billion per year. This pathology of bone can be categorized into two of the forms: primary forms and secondary forms. The primary osteoporosis is categorized by a liberal mineral bone that is absent as a meaning of aging of people as well as influenced by the variations in hormones related to sex. Instead, different pathologies as well as the use of specific medications that affect skeleton health which can induce secondary osteoporosis. The primary form of osteoporosis consists of postmenopausal or senile disease (type I or type II). Most of the time aged ranges from 50 to 65 years, type I osteoporosis occurred in a subgroup of postmenopausal female because of the productivity of consequent trabecular and estrogen bone resorption. Mainly involve the spine and wrist in this set of female pattern of fracture. The postmenopausal bone loss itself which is no left any evidence and causes any symptoms and therefore, the liberal bone damage has been considered as ‘silent thief’ or ‘the silent epidemic’. The characteristic fracture of Type II osteoporosis consists of fractures of pelvis bone, hip, tibia, and proximal humerus.
References
Christodoulou,, C., and C. Cooper. “What Is Osteoporosis?” Postgrad Med Journal, vol. 79, no. 929, 1 Mar. 2003, pp. 133–138.
Alkhaldi, Mishaal M, and Stuart L Porter. “Exercise Intervention for Osteoporosis Prevention in Postmenopausal Women: A Systematic Review.” Journal of Novel Physiotherapies, vol. 07, no. 01, 26 Dec. 2016.
F. Cosman, et al. “Clinician’s Guide to Prevention and Treatment of Osteoporosis.” Osteoporos Int, 15 Aug. 2014, pp. 2359–2381.
Gass, Margery, and Bess Dawson-Hughes. “Preventing Osteoporosis-Related Fractures: An Overview.” The American Journal of Medicine, vol. 119, no. 4, 2006.
Gronholz,, M. Jill. “Prevention, Diagnosis, and Management of Osteoporosis-Related Fracture: A Multifactoral Osteopathic Approach.” Journal of the American Osteopathic Association (JAOA), vol. 108, no. 10, Oct. 2018, pp. 575–585.
Hazrati, Abdullah. “Osteoporosis and Metabolic Bone Disorders.” Academia Journal of Scientific Research, vol. 5, no. 8, Aug. 2017, pp. 237–238.
Kalkım, Aslı, and Şafak Dağhan. “Theory-Based Osteoporosis Prevention Education and Counseling Program for Women: A Randomized Controlled Trial.” Asian Nursing Research, vol. 11, no. 2, 2017, pp. 119–127.
Kling, Juliana M., et al. “Osteoporosis Prevention, Screening, and Treatment: A Review.” Journal of Women’s Health, vol. 23, no. 7, 2014, pp. 563–572.
Pisani, Paola, et al. “Major Osteoporotic Fragility Fractures: Risk Factor Updates and Societal Impact.” World Journal of Orthopedics, vol. 7, no. 3, 2016, p. 171.
Schürer, Christian, et al. “Fracture Risk and Risk Factors for Osteoporosis.” Deutsches Aerzteblatt Online, 2015.
Thulkar, Jyoti, and Shalini Singh. “Overview of Research Studies on Osteoporosis in Menopausal Women since the Last Decade.” Journal of Mid-Life Health, vol. 6, no. 3, 2015, p. 104.
How to cite this article?
| APA Style | Vyas. A and Sharma. G (2019). The Risk Factors and Prevention of Osteoporosis. Academic Journal of Medical and Health Care Sciences, 1(1), 12-17 |
| Chicago Style | |
| MLA Style | |
| DOI | |
| URL |